| Literature DB >> 29718591 |
Sehoon Park1,2, Chung Hee Baek3, Hyunjeong Cho4, Mi-Yeon Yu5, Yong Chul Kim5, Heounjeong Go6, Young Hoon Kim7, Jung Pyo Lee5,8, Sang Il Min9, Jongwon Ha9, Kyung Chul Moon10, Yon Su Kim1,2,5, Curie Ahn1,5, Su-Kil Park3, Hajeong Lee1,5.
Abstract
The prognosis of patients with allograft IgA nephropathy (IgAN) requires further investigation. We performed a bicenter retrospective cohort study on kidney transplant recipients diagnosed with IgAN in allograft biopsy. Recipients without allograft IgAN but with known IgAN before transplantation were included as the control group. We investigated the associations between clinicopathological characteristics, including allograft crescents, and the risk of death-censored graft failure. In total, 1256 IgAN patients in both pre- and posttransplant stages were included. Among them, 559 were diagnosed with allograft IgAN, which was a time-dependent risk factor for worse prognosis (adjusted hazard ratio = 5.009 [3.610-6.951]; P < .001) during a median of 8.1 years of follow-up. Of the patients with allograft IgAN, 88 (15.9%) had glomerular crescents, including 40 patients (7.2%) with >10% crescent formation in the total biopsied glomeruli. The presence of glomerular crescents in IgAN was associated with a worse graft prognosis, and the association was still valid with the C scores of the current Oxford classification. In conclusion, allograft IgAN is a time-dependent event and is associated with worse graft outcomes. The pathological characteristics of allograft, particularly the degree of glomerular crescent formation, may represent important risk factors for a poor prognosis.Entities:
Keywords: clinical research/practice; graft survival; kidney (allograft) function/dysfunction; kidney transplantation/nephrology; pathology/histopathology
Mesh:
Year: 2018 PMID: 29718591 DOI: 10.1111/ajt.14908
Source DB: PubMed Journal: Am J Transplant ISSN: 1600-6135 Impact factor: 8.086